GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.